We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




X-Ray Techniques Probe the Clostridium Difficile Surface Layer

By LabMedica International staff writers
Posted on 11 Mar 2009
A team of molecular microbiologists has begun to shed light on the structural mechanism used by the pathogenic bacterium Clostridium difficile to adhere to and infect human enteric tissue.

Investigators at Imperial College (London, United Kingdom) used X-ray crystallography techniques to produce both high- and low-resolution images of the C. More...
difficile surface layer (S-layer). The S-layer contains a high-molecular-weight S-layer protein (HMW SLP) and its low-molecular-weight partner protein (LMW SLP).

Results published in the March 1, 2009, issue of the journal Molecular Microbiology revealed that the two types of protein formed a tightly associated noncovalent complex, the H/L complex. The 2.4-angstrom X-ray crystal structure of a shortened derivative of the LMW SLP revealed two domains. Domain 1 had a two-layer sandwich architecture while domain 2, predicted to orientate towards the external environment, contained a novel fold.

Small-angle X-ray scattering analysis of the H/L complex showed an elongated molecule, with the two SLPs arranged "end-to-end" interacting with each other through a small contact area. The way the LMW SLPs - which showed high sequence diversity - were aligned revealed a core of conserved residues. This type of structure could reflect functional conservation, while allowing for immune evasion through the sequence variation.

Dr. Neil Fairweather, professor of cell and molecular biology at Imperial College said, "This is the first time anyone has gained detailed information about the molecular structure of [the] C. difficile protective 'jacket,' because analyzing the two protein components is painstakingly difficult work. We are confident that continuing this work to better understand the formation of this protective coat and its exact function will reveal new targets for effective drugs to beat this dangerous pathogen, and could even lead to an effective vaccine."

Related Links:
Imperial College



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The addition of Biocare’s complementary IHC antibody, reagent and instrument portfolio enhances Agilent’s immunohistochemistry offering (Photo courtesy of Biocare Medical)

Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical

Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.